ConductScience.org, home
CLN3: CLN3 lysosomal/endosomal transmembrane protein, battenin
API referenceFor AI assistants

Gene · 1201

Papers1,287

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,287

Download this page as JSON
TitleJournalYearPMIDFound bySource
Key Reaction Mechanisms on ZnO during Vulcanization: A Study Based on Density Functional Theory Calculations and Supporting Experiments.ACS Omega202642729752PubTator, text miningPubMed
A 3D human retina model reveals a non-cell-autonomous and non-neuronal mechanism of photoreceptor loss in a lysosomal storage disorder.Sci Transl Med202642647598PubTator, text miningPubMed
High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk.Nat Genet202642552386PubTator, text miningPubMed
Thapsigargin-induced autophagic flux impairment and inflammation are potentiated by CLN3 deficiency and alleviated by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) in human ARPE-19 cells.Biochem Biophys Res Commun202642308764PubTator, text miningPubMed
Behavioral and emotional symptoms and quality of life in a national sample of individuals with CLN3 Batten disease.Orphanet J Rare Dis202642277918PubTator, text miningPubMed
Cognitive test performance in CLN3 Disease is associated with the CLN3 Staging System (CLN3SS).medRxiv202642238422PubTator, text miningPubMed
Mania in Juvenile Neuronal Ceroid Lipofuscinosis (CLN3 Disease): A Rare Neuropsychiatric Presentation in an Adolescent.J Child Neurol202642153457PubTator, text miningPubMed
PPARα and RXRα in the regulation of neuronal ceroid lipofuscinosis genes: implications for Batten disease therapy.NeuroImmune Pharm Ther202642146023PubTator, text miningPubMed
Toward Early Diagnosis and Therapeutic Discovery in CLN3 Disease: A Computational Biomarker Discovery Framework.medRxiv202642145637PubTator, text miningPubMed
Modeling CLN3 Batten disease in astrocytes reveals alterations in mitochondria homeostasis, fatty acid metabolism and oxidative stress response.J Biomed Sci202642129767PubTator, text miningPubMed
CRISPR and Beyond: Genome-Editing Strategies in Retinal Stem Cell Research.Cells202641892280PubTator, text miningPubMed
Bi-allelic variants in AP5Z1 and AP5B1 lead to retinal degeneration.HGG Adv202641830174PubTator, text miningPubMed
Longitudinal deep multi-omics profiling in a CLN3Δex7/8 minipig model identifies biomarker signatures of disease.Commun Med (Lond)202641775934PubTator, text miningPubMed
Altered transposon element-derived genes distort oxygen-free radical scavenger systems in FXD.NAR Mol Med202641768973PubTator, text miningPubMed
Clinical and Molecular Characteristics of Foveal Sparing Phenotype in Chinese Patients With Inherited Retinal Diseases.Transl Vis Sci Technol202641700794PubTator, text miningPubMed
Neurodevelopmental and Psychiatric Disorders and the Use of Psychotropic Medications in a National Sample of Individuals With Juvenile Neuronal Ceroid Lipofuscinosis.J Child Neurol202641642869PubTator, text miningPubMed
On the Utilization and Characterization of External Biotransformation Systems in In Vitro Toxicology: A Critical Review of the Scientific Literature with Guidance Recommendations.ACS Environ Au202641583864PubTator, text miningPubMed
Ironing out the details: Fe homeostasis in the shoot and root is regulated by distinct actions of BTS/BTSL1/2 and bHLH IVc subgroup transcription factors.Plant Cell202641578856PubTator, text miningPubMed
The multi-omics and Mendelian randomization analyses unveiled potential marker genes in the progression of glioblastoma.Medicine (Baltimore)202641578499PubTator, text miningPubMed
High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease risk.bioRxiv202641573945PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1201/papers

API referenceFor AI assistants